Stay updated on IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page.

Latest updates to the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.6.5 appears in the page footer, replacing v3.6.4, indicating a maintenance update to the ClinicalTrials.gov interface without changes to the study record.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe record history now displays a new site revision, v3.6.4, replacing the previous v3.6.3, signaling a backend or UI update to the page.SummaryDifference0.1%

- Check46 days agoChange DetectedThe study history shows a new revision entry for version v3.6.3, updating the record from v3.6.2.SummaryDifference0.1%

- Check54 days agoChange DetectedThe additions show a new revision entry 'Revision: v3.6.2' and the old 'Revision: v3.6.0' entry was removed. This updates the page's version history but does not alter the underlying study data.SummaryDifference0.1%

- Check68 days agoChange DetectedThe study record history now shows that the trial is no longer recruiting participants, and the record has been updated to revision 3.6.0.SummaryDifference0.4%

- Check75 days agoChange DetectedA new revision entry, v3.5.5, appears in the record history. The previous revision, v3.5.4, is removed from the visible list.SummaryDifference0.1%

Stay in the know with updates to IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page.